Preoperative Laboratory Parameters and Scorings Systems on Postoperative Pulmonary Complications in Thoracic Surgery
- Conditions
- Perioperative/Postoperative Complications
- Registration Number
- NCT04995939
- Lead Sponsor
- Atatürk Chest Diseases and Chest Surgery Training and Research Hospital
- Brief Summary
Postoperative pulmonary complications (PPC) emerge as a major risk that determines the morbidity and mortality of patients after surgery. PPCs affect the length of hospital stay and increase health costs. Because of this reason, it is important to predict PPCs before surgery. There are many studies on scoring systems that can be effective in predicting PPCs. The most frequently used ones are the Assess Respiratory Risk in Surgical Patients in Catalonia (ARISCAT) risk index, the Nutritional Risk Score (NRS), and the American Society of Anesthesiologist (ASA) score. ARISCAT risk index is mostly evaluated in operations performed other than thoracic surgery. Since the thoracic wall, mediastinum or lungs are directly intervened in thoracic surgery operations, the expected PPCs in these patients may be different from those expected in other surgical groups. Therefore, the ARISCAT risk index may be insufficient to evaluate PPCs in thoracic surgery.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 130
- Patients who will undergo elective thoracotomy or video assisted thoracic surgery with general anesthesia
- BMI < 35 kg/m2
- Age 18 - 75 years old
- Expected operative time more than 60 minutes
- History of lung surgery
- Advanced lung-heart disease
- Having a previous COVID-19 pneumonia
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Distribution of patients who developed one or more postoperative pulmonary complications according to preoperative neutrophil/lymphocyte ratio, albumin value, ARISCAT risk index, nutritional risk score, and ASA physical status. Time to preoperative visit and through study completion, an average of three months. 1. Effectiveness of the ARISCAT risk scoring index \[ Time Frame: postoperative first 30 days \]
to investigate the effectiveness of the ARISCAT risk scoring index in predicting the development of PPC in patients undergoing thoracic surgery.
2. Correlation between ASA physical status (1-3) and PPC \[ Time Frame: postoperative first 30 days \]
3. Correlation between NRS ( nutritional risk score) score (0-3) and PPC \[ Time Frame: postoperative first 30 days \]
4. Correlation between preoperative albumin values (gram / dl) and PPC \[ Time Frame: postoperative first 30 days \]
5. Correlation between preoperative neutrophil/lymphocyte ratio and PPC \[ Time Frame: postoperative first 30 days \]
- Secondary Outcome Measures
Name Time Method Distribution of patients who developed one or more postoperative pulmonary complications according to age, gender, BMI and preoperative SpO2 level. Time to preoperative visit and up to 30 days. 1. Correlation between age (years) and PPC \[ Time Frame: postoperative first 30 days
2. Correlation between gender(male or female) and PPC \[ Time Frame: postoperative first 30 days \]
3. Correlation between BMI (kg/m\^2) and PPC \[ Time Frame: postoperative first 30 days \]
4. Correlation between Preoperative Sp02(\>96%, 91%-95%, \<90%) and PPC \[ Time Frame: postoperative first 30 days \]
Trial Locations
- Locations (1)
Atatürk Chest Diseases and Chest Surgery Training and Research Hospital
🇹🇷Ankara, Keçioören, Turkey